Author Correction: EGFR-ERK induced activation of GRHL1 promotes cell cycle progression by up-regulating cell cycle related genes in lung cancer.

IF 8.1 1区生物学 Q1 CELL BIOLOGY Cell Death & Disease Pub Date : 2024-11-04 DOI:10.1038/s41419-024-07055-0

Yiming He, Mingxi Gan, Yanan Wang, Tong Huang, Jianbin Wang, Tianyu Han, Bentong Yu

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

作者更正：表皮生长因子受体-ERK诱导激活的GRHL1通过上调肺癌细胞周期相关基因促进细胞周期进展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Cell Death & Disease CELL BIOLOGY-

CiteScore

15.10

自引率

2.20%

发文量

935

审稿时长

2 months

期刊介绍： Brought to readers by the editorial team of Cell Death & Differentiation, Cell Death & Disease is an online peer-reviewed journal specializing in translational cell death research. It covers a wide range of topics in experimental and internal medicine, including cancer, immunity, neuroscience, and now cancer metabolism. Cell Death & Disease seeks to encompass the breadth of translational implications of cell death, and topics of particular concentration will include, but are not limited to, the following: Experimental medicine Cancer Immunity Internal medicine Neuroscience Cancer metabolism

期刊最新文献

Author Correction: EGFR-ERK induced activation of GRHL1 promotes cell cycle progression by up-regulating cell cycle related genes in lung cancer. VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN. G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1. Inhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis. Ror2 signaling regulated by differential Wnt proteins determines pathological fate of muscle mesenchymal progenitors.